Mergers & Acquisitions Analysis

Lilly to Spotlight Growing Hematology Portfolio at 2026 EHA Annual Meeting: Key Data and Strategic Implications

EMA · 6 min

Viridian Partners with WuXi Bio for Eye Drug Supply Amid FDA Decision

FDA · 4 min

Gilead's $140M Deal with Yuhan: Implications for Pharma

2 min

Roche's Licensing Deal for Xofluza: Implications and Insights

3 min